1999
156
Boer, G.J., Van Esseveldt, K.E., Van der Geest, B.A.M., Duindam, H., Rietveld, W.J., Vasopressin-deficient suprachiasmatic nucleus (SCN) grafts re-instate circadian rhythmcity in SCN-lesioned arhythmic rats, Neuroscience 89, 375-385 (1999)
155
Van Esseveldt, K.E., Van der Geest, B.A.M.,Duindam, H., Rietveld, W.P., Boer, G.J., Circadian rhythmicity of vasopressin levels in the cerebrospinal fluid of suprachiasmatic nucleus-lesioned and -grafted rats, J. Biol. Rhythms 14, 27-35 (1999)

1997
137
Van Esseveldt, K.E., Liu, R., Hermens, W.T.J.M.C., Verhaagen, J., Boer, G.J., Adenoviral vector-mediated gene transfer and neurotransplantation: possibilities and limitations in grafting of the fetal suprachiasmatic nucleus, J. Neurosc. Meth. 71, 113-123 (1997) 

1996
131
Korting, C, Van Zwieten, E.J., Boer, G.J., Ravid, R. and Swaab, D.F. Increase in vasopressin binding sites in the human choroid plexus in Alzheimer's disease. Brain Res., 706, 151-154 (1996)

1995
125
Boer, G.J., Feenstra, M.G.P., Botterblom, M.J.A., Korse, V., Te Riele, P., Early postnatal appearance of enhanced noradrenaline content in the brain of vasopressin-deficient Brattleboro rat; normal adrenoceptor densities and influences of vasopressin treatment, Int. J. Develop. Neurosc., 13, 63-74 (1995)

1994
122
Boer, G.J., Quak, J., De Vries, M.C., Heinsbroek, R.P.W., Mild sustained effects of neonatal vasopressin and oxytocin treatment on brain growth and behavior of rat. Peptides, 15, 229-236 (1994)

1993
113
Boer, G.J., Snijdewint, F.G.M., Licht, R., te Riele, P., Increased loss of brain DNA in the neonatal vasopressin-deficient Brattleboro rat, but not in normal rat treated with vasopressin antagonist. Neurosci. Lett. 156, 17-20 (1993)
112
Boer, G.J. Vasopressin and oxytocin receptors in the developing brain. In: I.S. Zagon and P.J. McLaughlin (Eds.) Receptors in the Developing Nervous System, Chapman & Hall, London (1993) pp. 225-248.
105
Van der Post, J.A.M., Konijnenberg, A., Boer, K., Schaap, M.C.L., Van Boxtel, C.E.A., Sturk, A., Boer, G.J., Swaab, D.F., Gestational hypertension is not associated with altered platelet vasopressin binding and cytosolic Ca2+ concentration. Am. J. Obstet. 169, 1169-1178 (1993)

1991
94
Boer, G.J., Neuropeptides: a new class of transmitters, a new class of functional teratogens. In: Fujii, T. and Boer, G.J. (Eds.) Functional Neuroteratology of Short-term Exposure to Drugs - Correlation between Structural or Biochemical Alterations and Functional Endpoints. Teikyo University Press (1991) pp. 73-85.
91
Nicholson, H.D., Guldenaar, S.E.F., Boer, G.J. and Pickering, B.T., Testi¬cular oxytocin: effects of intratesticular oxytocin in the rat. J. Endo¬crinology 130, 231-238 (1991)

1990
87
Boer, G.J. and Griffioen, H.A., Developmental and functional aspects of grafting of the suprachiasmatic nucleus in the Brattleboro rat and the arhythmic rat. Eur. J. Morphology 28, 330-345 (1990)
83
Gonzalez, B.J., Leroux, P., Boer, G.J. and Vaudry, H., Expression of somatostatin receptors is impaired in the cerebellum of developing Brattleboro rats. Brain Res, 532, 115-119 (1990).
80
Van Tol, H.H.M., Snijdewint, F.G.M., Boer, G.J. and Burbach, P.H., Hypothalamic oxytocin mRNA during development of the Brattleboro rat. Neurosci. Res. Comm. 7, 25-33 (1990)

1989
78
Herzberg, N.H., Goudsmit, E., Kruisbrink, J. and Boer, G.J., Testosterone treatment restores reduced vasopressin binding sites in the kidney of the aged rat. J. Endocrinol., 123, 59-63 (1989)
77
Shewey, L.M., Boer, G.J., Szot, P. and Dorsa, D.M., Regulation of vasopressin receptors and phosphoinositide hydrolysis in the septum of heterozygous and homozygous Brattleboro rats. Neuroendocrinology 50, 292-298 (1989)
76
Snijdewint, F.G.M., Van Leeuwen, F.W. and Boer, G.J., Ontogeny of vasopressin and oxytocin binding sites in the brain of Wistar and Brattleboro rats as demonstrated by lightmicroscopical autoradiography. J. Chem. Neuroanatomy 2, 3-17 (1989)

1988
75
Boer, G.J., Snijdewint, F.G.M. and Swaab, D.F., Neuropeptides and functional neuroteratology. Progr. Brain Res. 73, 245-264 (1988)
74
Boer, G.J., Van Heerikhuize, J.J. and Van der Woude, T.P., Elevated serum oxytocin of the vasopressin deficient Brattleboro rat is present throughout life and is not sensitive to treatment with vasopressin. Acta Endocrinol. 117, 442-450 (1988)
73
Kruisbrink, J., Mirmiran, M. and Boer, G.J., Effects of enhanced cerebrospinal fluid levels of vasopressin, vasopressin antagonist and vasoactive intestinal polypeptide on circadian rhythm and sleep wake patterns in rat, In: Sleep '86, eds. W.P. Koella, F. Obál, H. Schulz, P. Visser, Gustav Fischer Verlag, Stuttgart (1988) 332-334
72
Kruisbrink J., Van Heerikhuize, J.J. and Boer, G.J., Osmoregulation with long term enhanced cerebrospinal fluid levels of vasopressin or vasoactive intestinal polypeptide. J. Endocrinol. 117, 207-214 (1988) 
70
Snijdewint, F.G.M., Boer, G.J. and Swaab, D.F., Prenatal development of the Brattleboro rat is influenced by genotype and lysine vasopressin treatment of the mother. Biol. Neonate 53, 295-304 (1988)
69
Snijdewint, F.G.M. and Boer, G.J., Neonatal treatment with vasopressin antagonist dP[Tyr(Me)2]AVP, but not with vasopressin antagonist d(CH2)5[Tyr(Me)2]AVP, inhibits body and brain development and induces polyuria in the rat. Neurotoxicol. Teratol. 10, 321-325 (1988)

1987
67
Boer, G.J., Development of vasopressin systems and their functions. In: 'Vasopressin; principles and properties', D.M. Gash and G.J. Boer (Eds.), Plenum Press, N.Y. (1987) 117-174 
65
Kruisbrink, J., Mirmiran, M., V.d. Woude, T.P. and Boer G.J., Effects of enhanced cerebrospinal fluid levels of vasopressin, vasopressin antagonist or vasoactive intestinal polypeptide on circadian sleep wake rhythm in the rat. Brain Res. 419, 76-86 (1987)

1986
62
Kruisbrink, J., Van der Woude, T.P., Boer, G.J. and Mirmiran, M., Manipulation of vasopressin level in the cerebrospinal fluid of the rat by means of an easily interchangeable controlled delivery Accurel mini device. J. Neurosci. Meth. 17, 103-108 (1986)
61
Kruisbrink, J. and Boer, G.J., The use of [3H]vasopressin for in vivo studies of controlled drug delivery from an Accurel/collodion device in the Brattleboro rat. J. Pharm. Pharmacol. 38, 893-897 (1986)
60
Ravid, R., Swaab, D.F., Van der Woude, T.P. and Boer, G.J., Immunocytochemically stained binding sites for oxytocin and alpha melanocyte stimulating hormone in rat brain following ventricular administration. Brain Res. 379, 404-408 (1986)
59
Ravid, R., Swaab, D.F. and Van der Woude, Tj.P. and Boer, G.J., Immunocytochemicallystained vasopressin binding sites in rat brain Ventricular application of vasopressin/Accurel in the Brattleboro rat. J. Neurol. Sci. 76, 317-333 (1986)
58
Snijdewint, F.G.M. and Boer, G.J., Vasopressin and vasopressin antagonists applied to neonatal Wistar rat: effects on body and brain development and water metabolism. Neurobehav. Toxicol. Teratol. 8, 213-217 (1986)
57
Södersten, P., Boer, G.J., De Vries, G.J., Buijs, R.M. and Melin, P., Effects of vasopressin on female sexual behavior in male rats. Neurosci. Lett. 69, 188-191 (1986)
55
Van der Sluis, P.J., Boer, G.J. and Swaab, D.F., Vasopressin and oxytocin in the developing rat brain as shown by isoelectric focusing of radioimmunoassayable peptides. Developm. Brain Res. 26, 85-90 (1986)
54
Van Tol, H.H.M., Snijdewint, F.G.M., Boer, G.J. and Burbach, J.P.H., Postnatal development of vasopressin mRNA content in supraoptic and paraventricular nucleus of the Wistar rat. Neurosci. Lett. 65, 1-6 (1986)
53
Van Tol, H.H.M., Voorhuis, T.A.M., Snijdewint, F.G.M., Boer, G.J. and Burbach, J.P.H., Vasopressin gene expression is alternated in the fetal Brattleboro rat. FEBS letters 204, 101-105 (1986)

1985
52
Boer, G.J., Vasopressin and brain development; studies using the Brattleboro rat. Peptides 6, Suppl. 1, 49-62 (1985)
51
Boer, G.J. and Swaab, D.F., Neuropeptide effects on brain development to be expected from behavioral teratology. Peptides 6, Suppl. 2, 21-28 (1985)
50
Boer, G.J., Hall, K. and Sara, V.R., Transient enhancement of serum somatostatin levels prior to weaning of growth impaired vasopressin deficient Brattleboro rats. J. Developm. Physiol. 7, 321-327 (1985)
49
Boer, G.J., Gash, D.M., Dick, L. and Schluter, N., Vasopressin neuron survival in neonatal Brattleboro rats; critical factors in graft development and innervation of the host brain. Neuroscience 15, 1087-1109 (1985)
48
Oosterbaan, H.P., Swaab, D.F. and Boer, G.J., Oxytocin and vasopressin in the rat do not readily pass from the mother to the amniotic fluid in late pregnancy. J. Develop. Phys. 7, 55-62 (1985)
47
Oosterbaan, H.P., Swaab, D.F., and Boer, G.J., The origin of amniotic oxytocin and vasopressin and their relationship to intra uterine growth retardation. Proceedings of Int. Symposium `Physiological Development of Fetus and Newborn', C.J. Jones and P.W. Nathanielz (Eds.), Academic Press, London (1985) 89-92 
46
Oosterbaan, H.P., Swaab, D.F. and Boer, G.J., Increased amniotic vasopressin levels in experimentally growth retarded rat foetuses. J. Devel. Physiol. 7, 89-97 (1985)
45
Snijdewint, F.G.M., Boer, G.J. and Swaab, D.F., Body and brain growth following continuous perinatal administration of arginine and lysine vasopressin to the homozygous Brattleboro rat. Developm. Brain Res. 22, 269-277 (1985)

1984
44
Boer, G.J. and Kruisbrink, J., Effects of continuousadministration of oxytocin by an Accurel device on parturition in the rat and on development and diuresis in the offspring. J. Endocr. 101, 121-129 (1984)
43
Boer, G.J., Dozy, H.M. and Uylings, H.B.M., Cerebellar DNA and tissue water changes in the brain of diabetes insipidus Brattleboro rats are already present at birth. Int. J. Devel. Neurosci. 2, 301-304 (1984)
42
Boer, G.J., Schluter, N. and Gash, D.H., A procedure for small volume brain grafting; vasopressin cells in neonatal and adult Brattleboro rats. J. Neurosci. Meth. 11, 39-45 (1984).
41
Boer, G.J., Kragten, J. and Swaab, D.F., Vasopressin fails to restore postnatally the stunted brain development in the Brattleboro rat, but affects water metabolism permanently. Neurobehav. Toxicol. & Teratol. 6, 103-109 (1984)
40
Boer, G.J., Van der Woude, T.P., Kruisbrink, J. and Van Heerikhuize, J., Succesful ventricular application of the miniaturized controlled delivery Accurel technique for sustained enhancement of cerebrospinal fluid peptide levels in the rat. J. Neurosci. Meth. 11, 281-289 (1984)
39
Kruisbrink, J. and Boer, G.J., Controlled long term release of small peptide hormones using the new microporous polypropylene polymer. Its application for vasopressin in the Brattleboro rat and its potential perinatal use. J. Pharm. Sci. 73, 1713-1718 (1984)

1983
38
Boer, G.J. and Swaab, D.F., Long term effects on brain and behaviour of early treatments with neuropeptides. In: Application of Behavioral Pharmacology in Toxicology, G. Zbinden, V. Cuomo, G. Racagni and B. Weiss (eds.), Raven Press, New York (1983) 251-263
37
Boer, G.J., Kruisbrink, J. and Van Pelt Heerschap, H., Long term and constant release of vasopressin from Accurel tubing; implantation in the Brattleboro rat. J. Endocrinol. 98, 147-152 (1983)
36
Boer, G.J. and Patel, A.J., Disorders of cell acquisition in the brain of Brattleboro rats deficient for vasopression. Neurochem. Internat. 5, 463-469 (1983)
35
Boer, G.J. and Rieutort, M., Serum levels of growth hormone during the stunted postnatal development of th evasopressin deficient Brattleboro rat. J. Endocrinol. 98, 351-356 (1983)
34
Gash, D.M., Boer, G.J., Notter, M.F.D. and Sladek Jr., J.R., Transplanted vasopressin neurons and central nervous system effects of vasopressin. In: The Neurohypophysis, B.A. Cross and G. Leng (eds.), Progress in Brain Research, Vol. 60, Elsevier Biomedical Press, Amsterdam (1983) 189-195
33
Gash, D.M., Boer, G.J., Notter, M.F.D. and Sladek Jr., J.R., Development and function of transplanted vasopressin neurons. Psychopharm. Bull. 19, 308-310 (1983)
31
Kok, T., Van der Sluis, P.J. and Boer, G.J., Chemical identification of vasopressin immunoreactive material present in the rat suprachiasmatic nucleus. Neuropeptides 3, 255-262 (1983)

1982
26
Boer, G.J., Van Rheenen Verberg, C.M.F. and Uylings, H.B.M., Impaired brain development of the diabetes insipidus Brattleboro rat. Dev. Brain Res. 3, 557-575 (1982)
25
Boer, G.J., Boer, K. and Swaab, D.F., On the reproductive and developmental differences within the Brattleboro strain. Ann. N.Y. Acad. Sci. 394, 37-47 (1982)
24
Boer, G.J., Uylings, H.B.M., Patel, A.J., Boer, K. and Kragten, R., The regional impairment of brain development in the Brattleboro diabetes insipidus rat; some vasopressin supplementation studies. Ann. N.Y. Acad. Sci. 394, 703-719 (1982)
23
Grimmelikhuijzen, C.J.K., Dierickx, K. and Boer, G.J., An ancestral oxytocin/vasopressin like peptide is present in the nervous system of hydra. Neuroscience 7, 3191-3199 (1982)
21
Swaab, D.F., Boer, G.J., Boer, K., Oosterbaan, H.P. and Oosting, P.R., Neurohypophysial and intermediate lobe peptides in intrauterine growth and labour. In: Neuroendocrinology of Vasopressin, Corticoliberin and opiomelanocortins, A.J. Baertschi and J.J. Dreifuss (eds.), Academic Press, London (1982) 343-352

1981
20
Boer, K., Boer, G.J. and Swaab, D.F., Reproduction in Brattleboro rats with diabetes insipidus. J. Reprod. Fertil. 61, 273-280 (1981)

1980
18
Boer, G.J., Swaab, D.F., Uylings, H.B.M., Boer, K., Buijs, R.M. and Velis, D.N., Neuropeptides in rat brain development. In: Adaptive Capabilities of the Nervous System, P.S. McConnell, G.J. Boer, H.J. Romijn, N.E. Van de Poll and M.A. Corner (eds.), Progress in Brain Research, Vol. 53, Elsevier, Amsterdam (1980) 207-227
16
Boer, G.J., Buijs, R.M., Swaab, D.F. and De Vries, G.J., Vasopressin and the developing rat brain. Peptides 1 (Suppl. 1), 203-209 (1980)

1978
12
Boer, G.J., Uylings, H.B.M., Van Rheenen Verberg, C.M.F. and Fisser, B, Postnatal brain development in rats with hereditary diabetes insipidus (Brattleboro strain). In: Hormones and Brain Development, G. Dörner and M. Kawasaki (eds.), Elsevier/North Holland Biomedical Press, Amsterdam (1978) 253-258